 Guj Nar Val Fer & Chem LCommodity Chemicals | GNFC Managing Director change: Sanjeev Kumar replaces Rajkumar Beniwal10 Sept 2026Ceo Appointed External×4 | pending | ₹563 | 8,273 Cr | 8.0vs 17.0 | 10.3% | +39.8% |
 Vikram SolarOther Electrical Equipment | Vikram Solar AGM: shareholders approve new CEO Sameer Nagpal, re-appoint Chairman Gyanesh Chaudhary5 Aug 2026Ceo Appointed External×2 | -8.4% +1.2% -7.8% | ₹167 | 6,059 Cr | 16.5vs 26.2 | 17.2% | +37.9% |
 Latent View AnalyticsComputers - Software & Consulting | Latent View Analytics appoints Sonal Ramrakhiani as CEO and KMP1 Aug 2026Ceo Appointed External×4 | -5.5% -8.7% -16.2% | ₹253 | 5,243 Cr | 26.8vs 16.6 | 14.1% | +21.6% |
 JustdialInternet & Catalogue Retail | Just Dial appoints new CEO and CFO; director steps down10 Jul 2026Ceo Appointed External×3 | +41.9% +27.5% +19.6% | ₹670 | 5,698 Cr | 15.7vs 15.7 | 11.0% | +16.2% |
 The South Indian BankPrivate Sector Bank | South Indian Bank gets RBI nod for new MD and CEO Mahesh Pai8 Jul 2026Ceo Appointed External×2 | -7.2% -6.7% -3.7% | ₹46.18 | 12,090 Cr | 8.0vs 12.4 | — | — |
 RaymondIndustrial Products | Raymond appoints former BEL CMD Bhanu Prakash Srivastava as CEO Defence6 Jul 2026Ceo Appointed External×2 | -0.1% -0.4% +2.3% | ₹1,003 | 6,675 Cr | 180.1vs 26.9 | -2.8% | +15.5% |
 Can Fin HomesHousing Finance Company | RBI approves Shailesh Kumar Singh as Deputy Managing Director3 Jul 2026Ceo Appointed External | +1.1% +0.4% -10.1% | ₹781 | 10,400 Cr | 9.2vs 13.3 | — | +7.4% |
 Bliss GVS PharmaPharmaceuticals | New CEO appointed, existing CEO steps aside to focus on MD role3 Jul 2026Ceo Appointed External×2 | +0.6% +2.2% -2.4% | ₹721 | 7,647 Cr | 56.0vs 28.9 | 15.1% | +37.6% |
 Syngene InternationalHealthcare Research Analytics & Technology | Siddharth Mittal appointed as MD and CEO of Syngene International effective July 1, 20261 Jul 2026Ceo Appointed External | +2.3% -2.3% -6.7% | ₹383 | 15,466 Cr | 69.7vs 22.8 | 7.5% | -15.8% |
 Ircon InternationalCivil Construction | Shri Saleem Ahmad assumes additional charge as CMD and CEO of IRCON1 Jul 2026Ceo Appointed External | +2.4% +0.3% +0.3% | ₹113 | 10,661 Cr | 20.4vs 14.9 | 4.8% | +9.5% |
 Cohance LifesciencesPharmaceuticals | Cohance Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.14 Jun 2026Ceo Appointed External×3 | +1.4% +7.8% +1.7% | ₹440 | 16,817 Cr | 108.3vs 28.9 | 4.1% | -23.1% |
